Forbes November 25, 2025
The era of predictive genomics is rapidly reshaping how we think about disease, risk and lifelong health. Recent advances in whole-genome sequencing have equipped clinicians with insights into our bodies that are more granular and precise than ever before. With DNA and RNA sequencing, proteomics and molecular readouts, medicine now moves beyond traditional labs and imaging. It is opening a new world where the stories written in our genome help predict—and sometimes pre-empt—illness.
Yet, as explored in my book, Destiny’s Child No Longer, this revolution is more than just technological progress. It is a moment of great clinical and ethical consequence. It is challenging us to balance the promise of early prediction with the responsibilities that come with beginning to...
Today's Sponsors
Today's Sponsor